Which set of tests would be the most useful in diagnosing an acute myocardial infarction?

Which set of tests would be the most useful in diagnosing an acute myocardial infarction?

• A. AST, LD, CK-MB
• B. LD, CK-MB, troponin
• C. CK-MB, troponin, myoglobin
• D. LD, troponin, myoglobin

Answer: (C)

The key idea is using cardiac biomarkers that reflect myocardial injury with both early visibility and strong specificity. Troponin is the most specific and sensitive indicator of myocardial necrosis, rising with heart muscle damage and staying elevated for an extended period, which helps confirm an infarct even after other causes of chest pain have been ruled out. CK-MB is helpful because it rises in a relatively short time around the onset of infarction and returns to baseline sooner than troponin, making it useful for timing and detecting reinfarction. Myoglobin appears very early, within hours, providing a first clue to myocardial injury, but it is not specific to heart muscle and can be elevated in skeletal muscle injury as well, so it’s most informative when interpreted alongside troponin. Choosing a panel that includes troponin, CK-MB, and myoglobin covers both early detection and high specificity, giving a clearer and faster diagnosis of acute myocardial infarction. Other panels replace one of these with markers that are either less specific or slower to rise, such as AST or LDH, or omit a marker that adds early detection or timing information, making them less optimal for diagnosing AMI.

The key idea is using cardiac biomarkers that reflect myocardial injury with both early visibility and strong specificity. Troponin is the most specific and sensitive indicator of myocardial necrosis, rising with heart muscle damage and staying elevated for an extended period, which helps confirm an infarct even after other causes of chest pain have been ruled out. CK-MB is helpful because it rises in a relatively short time around the onset of infarction and returns to baseline sooner than troponin, making it useful for timing and detecting reinfarction. Myoglobin appears very early, within hours, providing a first clue to myocardial injury, but it is not specific to heart muscle and can be elevated in skeletal muscle injury as well, so it’s most informative when interpreted alongside troponin.

Choosing a panel that includes troponin, CK-MB, and myoglobin covers both early detection and high specificity, giving a clearer and faster diagnosis of acute myocardial infarction. Other panels replace one of these with markers that are either less specific or slower to rise, such as AST or LDH, or omit a marker that adds early detection or timing information, making them less optimal for diagnosing AMI.